Amrutanjan-Healt Stock/Share Prices, Buy and Sell Amrutanjan-Healt NSE Stocks

Market Snapshot

BSE Sensex: 48564.27 -0.96%
BSE 500: 18713.54 -1.35%
BSE 200: 6042.13 -1.29%
BSE 100: 14417.1 -1.21%
BSE Mid-Cap: 18524.83 -2.01%
BSE Small-Cap: 18329.79 -1.89%
BANKEX: 36027.8 -1.40%
BSE IT Sector: 25924.12 -1.63%
Nifty 50: 14281.3 -1.06%
Nifty 500: 11776.2 -1.30%
Nifty 200: 7392.8 -1.27%
Nifty 100: 14390.05 -1.16%
Nifty Midcap 100: 21470.15 -2.12%
Nifty Small 100: 7270.65 -1.77%
Nifty IT: 25916.25 -1.69%
Nifty PSU Bank: 1889.95 -2.44%

News:

Mindtree Q3 PAT rises 29% QoQ ...
Trident gains after Q3 PAT zoo...
Mastek Ltd leads losers in A g...
Rallis India Q3 PAT jumps 20% ...
Williamson Magor & Company Ltd...

Amrutanjan Health Care Ltd NSE / BSE
Pharmaceuticals, Small Cap

Invest

18 Jan 2021 | 04:14 PM

525.10

-14.50 (-2.69%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

6.92%

Return (1Y)

Underperformed Nifty 50 by 9.9%
More Volatile

3.33%

Standard Deviation (1Y)

Higher than Nifty 50 by 1.34%
Not so consistent

5/12

Months

underperformed Nifty 50
AxisDirect View

No View

52 Week High-Low

589

253

News & Announcements

Amrutanjan Health Care announces cessation of director
35 days ago

Amrutanjan Health Care announces cessation of director

14 - Dec - 2020 12:00 AM | 35 days ago

Amrutanjan Health Care announced that V. Swaminathan, (DIN 06953687) has stepped down from the position of “Non-executive Independent Director” of the Company with effect from 12 December 2020.
Powered by Capital Market - Live News
Amrutanjan Health Care standalone net profit rises 180.36% in the September 2020 quarter
66 days ago

Amrutanjan Health Care standalone net profit rises 180.36% in the September 2020 quarter

13 - Nov - 2020 12:00 AM | 66 days ago

Net profit of Amrutanjan Health Care rose 180.36% to Rs 23.55 crore in the quarter ended September 2020 as against Rs 8.40 crore during the previous quarter ended September 2019. Sales rose 23.13% to Rs 92.11 crore in the quarter ended September 2020 as against Rs 74.81 crore during the previous quarter ended September 2019.
Particulars Quarter Ended
Sep. 2020 Sep. 2019 % Var.
Sales 92.11 74.81 23
OPM % 30.70 15.48 -
PBDT 32.28 13.39 141
PBT 31.39 12.12 159
NP 23.55 8.40 180
Powered by Capital Market - Live News
Board of Amrutanjan Health Care recommends first interim dividend
67 days ago

Board of Amrutanjan Health Care recommends first interim dividend

12 - Nov - 2020 12:00 AM | 67 days ago

Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting held on 12 November 2020, inter alia, have recommended the first interim dividend of Rs 0.8 per equity Share (i.e. 80%) , subject to the approval of the shareholders.
Powered by Capital Market - Live News
Amrutanjan Health Care grants options
67 days ago

Amrutanjan Health Care grants options

12 - Nov - 2020 12:00 AM | 67 days ago

on 12 November 2020 has approved the grant of 1608 options convertible into equity shares of Re. 1 each ranking pari passu with the existing equity shares of the Company to select employee of the senior management under the Amrutanjan Health Care Limited ESOP Scheme 2020.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Amrutanjan Health Care Ltd has decreased by -17.46% since past 3 Months
FII shareholding in Amrutanjan Health Care Ltd has decreased by -55.31% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2020	Sep. 2019	% Var.
Sales	92.11	74.81	23
OPM %	30.70	15.48	-
PBDT	32.28	13.39	141
PBT	31.39	12.12	159
NP	23.55	8.40	180

General Notifications

My Notifications

Research Notifications

Amrutanjan Health Care Ltd NSE / BSE Pharmaceuticals, Small Cap

525.10 -14.50 (-2.69%)

News & Announcements

Price vs Volume

Stock Trivia

Amrutanjan Health Care Ltd NSE / BSE
Pharmaceuticals, Small Cap

525.10

-14.50 (-2.69%)